Stay updated on Pembrolizumab in Untreated Extensive SCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.

Latest updates to the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page
- Check3 days agoChange DetectedA revision tag on the page was updated from v3.5.2 to v3.5.3, indicating a system update; study content and displayed information remain unchanged.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded the keyword 'Small cell lung carcinoma' and a new 'resources' section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision history updated to include v3.5.0 and remove v3.4.3. This is a minor metadata update that does not affect study content or results.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.3 added in the page header, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page now displays Revision: v3.4.2, and a government funding/operating status notice and the earlier Revision: v3.4.1 were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Untreated Extensive SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated Extensive SCLC Clinical Trial page.